IR Contact

About Clinical Development Contract Manufacturing Consumers Media Investors Contact

Overview History Clinical Philosophy Leadership Advisory Boards Locations Stem for Life

Cell Therapeutics Development Amorcyte Athelos VSEL™ Technology Wound Technology Intellectual Property

Overview Enabling Development

Pharmaceuticals Stem Cell Banking

News Media Coverage Videos Images

Operating Divisions IR Events SEC Filings Email Alerts FAQs

Home Investor Relations IR Contact

IR Contact

Robin Smith, CEO
Phone: (212) 584-4174
email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Investor Email Registration Form

Quick Links

Receive Email Alerts
Receive RSS Feeds

Stock Quote